Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid for prevention of postoperative bleeding in total knee arthroplasty
2011-000766-35Phase 3Active
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of tranexamic acid in knee osteoarthritis (OA) (3 arms), sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Primary endpoint: Postoperative blood loss. Started Sep 2011; status: active.
02
Drugs
tranexamic acid
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2011-000766-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000766-35.